Sabra Health Care REIT (SBRA) Stock Forecast, Price & News

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SBRA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBRA, but not buy additional shares or sell existing shares.
View SBRA analyst ratings or view top-rated stocks.

9 Wall Street analysts have issued 12-month price targets for Sabra Health Care REIT's shares. Their SBRA share price forecasts range from $11.00 to $15.00. On average, they anticipate the company's share price to reach $13.15 in the next twelve months. This suggests that the stock has a possible downside of 5.3%.
View analysts price targets for SBRA or view top-rated stocks among Wall Street analysts.

Sabra Health Care REIT's stock was trading at $12.43 at the beginning of 2023. Since then, SBRA stock has increased by 11.7% and is now trading at $13.88.
View the best growth stocks for 2023 here.

Sabra Health Care REIT saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 13,650,000 shares, an increase of 54.6% from the August 15th total of 8,830,000 shares. Based on an average daily volume of 2,210,000 shares, the days-to-cover ratio is currently 6.2 days.
View Sabra Health Care REIT's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our SBRA earnings forecast.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) released its quarterly earnings results on Wednesday, May, 4th. The real estate investment trust reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative net margin of 19.63% and a negative trailing twelve-month return on equity of 4.05%. During the same period last year, the business posted $0.39 earnings per share.

Sabra Health Care REIT announced a quarterly dividend on Monday, August 7th. Stockholders of record on Thursday, August 17th will be paid a dividend of $0.30 per share on Thursday, August 31st. This represents a $1.20 annualized dividend and a yield of 8.65%. The ex-dividend date of this dividend is Wednesday, August 16th.
Read our dividend analysis for SBRA.

ETFs with the largest weight of Sabra Health Care REIT (NASDAQ:SBRA) stock in their portfolio include Invesco KBW Premium Yield Equity REIT ETF (KBWY), Principal Real Estate Active Opportunities ETF (BYRE), ALPS REIT Dividend Dogs ETF (RDOG), JPMorgan Realty Income ETF (JPRE), Cambria Global Real Estate ETF (BLDG), Hoya Capital High Dividend Yield ETF (RIET), Global X SuperDividend ETF (SDIV) and iShares Residential and Multisector Real Estate ETF (REZ).

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.61%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SBRA.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

Sabra Health Care REIT's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.34%), Principal Financial Group Inc. (8.95%), State Street Corp (5.33%), Bank of New York Mellon Corp (2.35%), Geode Capital Management LLC (2.33%) and LSV Asset Management (1.83%). Insiders that own company stock include Catherine Cusack, Harold W Jr Andrews, Michael J Foster and Michael Lourenco Costa.
View institutional ownership trends.

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SBRA stock can currently be purchased for approximately $13.88.

Sabra Health Care REIT (NASDAQ:SBRA) has a market capitalization of $3.21 billion and generates $624.81 million in revenue each year. The real estate investment trust earns $-77,610,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis.

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The official website for the company is www.sabrahealth.com. The real estate investment trust can be reached via phone at (888) 393-8248, via email at investorrelations@sabrahealth.com, or via fax at 949-679-8868.